Another previous investigation studied the role of SGLT-2 inhibitor on NAFLD in leptin-deficient ob/ob mice and showed that SGLT-2 inhibitor action was independent of leptin [56]. The gene discussed is SLC5A2; the disease is metabolic dysfunction-associated steatotic liver disease.